1. Home
  2. AMTB vs ODTX Comparison

AMTB vs ODTX Comparison

Compare AMTB & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amerant Bancorp Inc.

AMTB

Amerant Bancorp Inc.

N/A

Current Price

$30.27

Market Cap

1.2B

Sector

Finance

ML Signal

N/A

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$18.77

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMTB
ODTX
Founded
1979
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
AMTB
ODTX
Price
$30.27
$18.77
Analyst Decision
Hold
Strong Buy
Analyst Count
4
8
Target Price
$33.25
★ $34.67
AVG Volume (30 Days)
★ 390.9K
282.2K
Earning Date
10-22-2026
11-04-2026
Dividend Yield
★ 1.18%
N/A
EPS Growth
★ 386.36
N/A
EPS
★ 1.62
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.81
N/A
P/E Ratio
$18.73
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.81
$15.10
52 Week High
$31.00
$29.05

Technical Indicators

Market Signals
Indicator
AMTB
ODTX
Relative Strength Index (RSI) 57.08 45.36
Support Level $28.16 $15.73
Resistance Level $30.41 $19.60
Average True Range (ATR) 0.76 1.79
MACD 0.03 0.11
Stochastic Oscillator 60.05 18.74

Price Performance

Historical Comparison
AMTB
ODTX

About AMTB Amerant Bancorp Inc.

Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: